← All Sponsors
SPONSOR

Almirall, S.A.

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Dermatitis, AtopicEczema
NCT06526182 Phase 3
Recruiting

A Study of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis

Dermatitis, Atopic
Spain View Trial →